Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast December 26, 2024 Dr. Amit Sood is called the “Happiness Doctor” for a…
Originally broadcast December 20, 2024 Billionaires who dream of extending human life, including Elon Musk,…
Originally broadcast December 12, 2024 Nurse practitioners, at 385,000 strong in the U.S., are increasingly…
Originally broadcast December 5, 2024 HIV/AIDS experts are cautiously watching as President Trump and his…
Originally broadcast on November 27, 2024 Dr. Amit Sood is called the “Happiness Doctor” for…
Originally broadcast November 21, 2024 TV ads focused on health care issues — including transgender…